Friday, September 03, 2021 3:33:28 PM
Recent IPHA News
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juin 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang • Business Wire • 06/17/2024 05:00:00 AM
- Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial • Business Wire • 06/17/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 10:03:42 AM
- Innate Pharma présente les résultats positifs de l’étude de Phase 2 TELLOMAK évaluant lacutamab dans le mycosis fongoïde • Business Wire • 06/04/2024 05:00:00 AM
- Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides • Business Wire • 06/04/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 10:03:49 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences • Business Wire • 05/28/2024 05:00:00 AM
- Innate Pharma annonce sa participation à de prochaines conférences investisseurs • Business Wire • 05/28/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/24/2024 10:35:36 AM
- Innate Pharma partage les abstracts sélectionnés pour le congres annuel de l’ASCO 2024 • Business Wire • 05/24/2024 05:00:00 AM
- Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting • Business Wire • 05/24/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 08:00:44 PM
- Outcome of Innate Pharma’s 2024 Annual General Meeting • Business Wire • 05/23/2024 08:00:00 PM
- Résultats de l’Assemblée Générale mixte du 23 mai 2024 • Business Wire • 05/23/2024 08:00:00 PM
- Innate Pharma: Clarification Regarding SAR443579 Designation • Business Wire • 05/21/2024 05:00:00 AM
- Innate Pharma: Clarification concernant le statut de SAR443579 • Business Wire • 05/21/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2024 10:01:12 AM
- Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress • Business Wire • 05/15/2024 05:00:00 AM
- Innate Pharma partage les abstracts sélectionnés pour le congrès 2024 de l’EHA • Business Wire • 05/15/2024 05:00:00 AM
- Innate Pharma fait le point sur ses activités et publie ses résultats financiers pour le premier trimestre 2024 • Business Wire • 05/14/2024 05:00:00 AM
- Innate Pharma Reports First Quarter 2024 Business Update and Financial Results • Business Wire • 05/14/2024 05:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update • Business Wire • 05/07/2024 05:00:00 AM
- Innate Pharma organise une conférence téléphonique pour présenter ses résultats au premier trimestre 2024 • Business Wire • 05/07/2024 05:00:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM